| Pharmacovigilance in New Zealand: the role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines use. | |
| | |
MedLine Citation:
|
PMID: 18841188 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The New Zealand Pharmacovigilance Centre (NZPhvC) is the national centre responsible for monitoring adverse reactions to therapeutic products in New Zealand(NZ). The NZPhvC operates three pharmacovigilance programmes and this article explains how each of these programmes operate, focuses on their strengths and limitations, and looks to the future for medicines safety monitoring in NZ. |
| | |
Authors:
|
Desiree L Kunac; Mira Harrison-Woolrych; Michael V Tatley |
Related Documents
:
|
14731148 - Patient experience of time duration: strategies for 'slowing time' and 'accelerating ti... 12379058 - Changes in grazing behaviour of native and crossbred sheep in different seasons under s... 22473138 - Impressions and experience of non-neurologists in neurology. 8718408 - Elements of the employee selection process: interviewing operating room staff. 9634108 - Geriatric rhinitis: what it is, and how to treat it. 11941378 - Analgesia and the patient with osteoarthritis. |
Publication Detail:
|
Type: Journal Article; Review Date: 2008-10-03 |
Journal Detail:
|
Title: The New Zealand medical journal Volume: 121 ISSN: 1175-8716 ISO Abbreviation: N. Z. Med. J. Publication Date: 2008 Oct |
Date Detail:
|
Created Date: 2008-10-08 Completed Date: 2008-10-30 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0401067 Medline TA: N Z Med J Country: New Zealand |
Other Details:
|
Languages: eng Pagination: 76-89 Citation Subset: IM |
Affiliation:
|
NZPhvC, Department of Preventive and Social Medicine, University of Otago, P O Box 913, Dunedin, New Zealand. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adverse Drug Reaction Reporting Systems
/
organization & administration* Drug and Narcotic Control* Humans New Zealand Population Surveillance* |
| Comments/Corrections | |
Comment In:
|
N Z Med J. 2008 Oct 3;121(1283):9-11
[PMID:
18841179
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Program...
Next Document: Kava hepatotoxicity: a European view.